Our analysis indicated the high expression of CXCL8, CCL2, CXCL10, and CCL20 in prostate cancer tissues expressing a low expression level of SFMBT2, which is correlated with high Gleason scores (Figure 1F, Tables S4 and S5) [26]. This evidence concerns the gene CCL2 and prostate carcinoma.